SEC Form 4 · accession 0001615594-18-000015
Cibus, Inc. · CBUS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alain Godard
Director
Period of report
Feb 20, 2018
Accepted (ET)
Feb 22, 2018 · 6:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001705843
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 20, 2018 | M | 6,125 | $3.71 | A | 45,325 | D | |
| Common StockF2 | Feb 20, 2018 | S | 3,625 | $20.2268 | D | 41,700 | D | |
| Common StockF3 | Feb 20, 2018 | S | 1,900 | $21.2322 | D | 39,800 | D | |
| Common StockF4 | Feb 20, 2018 | S | 600 | $21.9008 | D | 39,200 | D | |
| Common Stock | Feb 21, 2018 | M | 13,700 | $3.58 | A | 52,900 | D | |
| Common StockF5 | Feb 21, 2018 | S | 13,300 | $19.188 | D | 39,600 | D | |
| Common Stock | Feb 22, 2018 | S | 400 | $19.00 | D | 39,200 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right-to-Buy) | $3.71 | Feb 20, 2018 | M | 6,125 | D | Jan 3, 2015 | Dec 3, 2024 | Common Stock | 6,125 | 0 | D |
| Stock Option (Right-to-Buy) | $3.5878 | Feb 21, 2018 | M | 13,700 | D | Apr 7, 2016 | Apr 7, 2026 | Common Stock | 13,700 | 84,300 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.77-20.76, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2-5 to this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.80-21.68, inclusive.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.84-21.94, inclusive.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00-19.44, inclusive.